Search

everythinglearnresearchcommunity

for

Search:↓

No link found between specific genes and female pattern hair loss.

Minoxidil effectively treats hair loss, works better for women, and requires consistent use.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

New compounds may soon be tested to treat excessive hair growth in women.

Finasteride caused enlarged breast tissue in a 62-year-old man.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

PCOS is managed with medication, lifestyle changes, and a healthy diet.

Androgens, like testosterone, are crucial for early testicular descent in rats.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Genetics and hormones cause hair loss; finasteride treats it safely.